IgG4-related disease

IgG4-related disease is a rare immune condition where the body produces excessive amounts of a specific antibody called IgG4, leading to chronic inflammation and tissue damage in various organs. This disease causes the formation of abnormal immune cell collections that scar and stiffen affected tissues, potentially impacting the pancreas, salivary glands, bile ducts, and other organs. Unlike typical autoimmune diseases that attack specific cells, IgG4-related disease creates a unique inflammatory pattern that can mimic cancer or other serious conditions, making diagnosis challenging. It predominantly affects middle-aged and older adults, with men being diagnosed more frequently than women.

IgG4-related disease appears across multiple medical specialties including rheumatology, gastroenterology, and oncology, because its symptoms and tissue changes can affect almost any organ system. The disease matters because it was only formally recognized and named in the early 2000s, yet it likely accounts for a significant portion of previously misdiagnosed inflammatory conditions. Research into this disease has fundamentally changed how doctors understand immune-mediated fibrosis—the scarring of tissues caused by immune activation—and has revealed that IgG4 antibodies play a more important role in disease than previously suspected.

The mechanism involves the body's immune system producing abnormally high levels of IgG4 antibodies, which are a minor antibody class that normally plays a subtle regulatory role in immunity. These IgG4 molecules accumulate in affected tissues and recruit immune cells called plasmablasts and regulatory T cells, which then trigger chronic inflammation and progressive scarring. Think of it like a faulty security system that sends excessive guards to a location, and rather than protecting the site, they cause damage and leave behind permanent scar tissue that interferes with normal organ function.

Understanding IgG4-related disease is crucial because it helps distinguish it from cancer, which it often mimics on imaging, potentially preventing unnecessary aggressive treatments. The disease also offers insights into how specific antibody types can drive chronic inflammation and fibrosis, knowledge that could lead to better treatments not only for this condition but for other fibrotic diseases affecting millions worldwide. Additionally, identifying IgG4-related disease enables doctors to prescribe appropriate immunosuppressive therapies that can halt disease progression and restore organ function.